ES2076274T3 - Sustancia cpc farmacologicamente activa, proceso para su preparacion y su utilizacion en la terapia. - Google Patents

Sustancia cpc farmacologicamente activa, proceso para su preparacion y su utilizacion en la terapia.

Info

Publication number
ES2076274T3
ES2076274T3 ES90119376T ES90119376T ES2076274T3 ES 2076274 T3 ES2076274 T3 ES 2076274T3 ES 90119376 T ES90119376 T ES 90119376T ES 90119376 T ES90119376 T ES 90119376T ES 2076274 T3 ES2076274 T3 ES 2076274T3
Authority
ES
Spain
Prior art keywords
disorders
diseases
human
preparation
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90119376T
Other languages
English (en)
Inventor
Predrag Dr Sc Sikiric
Marijan Mr Sc Petek
Ivo Mr Sc Rotkvic
Stjepan Mr Sc Mise
Simun Krizanac
Ivan Dr Udovicic
Ernest Dr Sc Suchanek
Marko Mr Sc Duvnjak
Jerka Dr Jukic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2076274T3 publication Critical patent/ES2076274T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

NUEVA SUSTANCIA BPC; SU PROCESO DE PREPARACION A PARTIR DEL JUGO GASTRICO HUMANO Y ANIMAL QUE COMPRENDE VARIOS PASOS DE PURIFICACION: CENTRIFUGACION, DIALISIS, INTERCAMBIO DE IONES, CROMOTOGRAFIA DE GALON Y LIOFILIZACION; DROGA PARA USO HUMANO Y VETERINARIO Y PROCESO PARA EL TRATAMIENTO DE ENFERMEDADES Y DESORDENES INDUCIDOS POR EL ESTRES, INFLAMACIONES Y EDEMAS, ENFERMEDADES Y DESORDENES DE ETIOLOGIA DOPAMINERGICA, PARA EL TRATAMIENTO DE DIABETES MELLITUS, DESORDENES Y ENFERMEDADES DEL TRAMO GASTROINTESTINAL, CORAZON, RIÑON, PANCREAS, HIGADO, TESTICULOS, HEMATOPOYETICA, SISTEMA ESQUELETICO Y NERVIOSO, DEMENCIAS, HERIDAS, QUEMADURAS, FRACTURAS, ENFERMEDADES VIRALES, MALIGNIDAD ; EN CIRUGIA; ALGUNOS DESORDENES DE LA FERTILIDAD Y DEL SISTEMA INMUNOLOGICO; PROTECCION CONTRA LA RADIACION POR IONIZACION; PARA USO VETERINARIO EN LA REPRODUCCION COMERCIAL.
ES90119376T 1989-09-12 1990-09-11 Sustancia cpc farmacologicamente activa, proceso para su preparacion y su utilizacion en la terapia. Expired - Lifetime ES2076274T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU176089A YU176089A (sh) 1989-09-12 1989-09-12 Postupak za pripremu supstancije bpc i supstancija bpc

Publications (1)

Publication Number Publication Date
ES2076274T3 true ES2076274T3 (es) 1995-11-01

Family

ID=25555483

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90119376T Expired - Lifetime ES2076274T3 (es) 1989-09-12 1990-09-11 Sustancia cpc farmacologicamente activa, proceso para su preparacion y su utilizacion en la terapia.

Country Status (9)

Country Link
US (1) US5288708A (es)
EP (1) EP0432400B1 (es)
AT (1) ATE125266T1 (es)
DE (1) DE69021024T2 (es)
DK (1) DK0432400T3 (es)
ES (1) ES2076274T3 (es)
GR (1) GR3017787T3 (es)
HU (1) HU211038A9 (es)
YU (1) YU176089A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE152734T1 (de) * 1992-05-30 1997-05-15 Sikiric Predrag Bpc-peptide, deren herstellung und verwendung
EP0624164B1 (en) * 1992-11-16 1998-02-11 Marijan Mr.Sc. Petek Peptides with organo-protective activity, process for their preparation and their use in the therapy
GB9311147D0 (en) * 1993-05-28 1993-07-14 Long Ashton Research Station Regulation of plant growth
AU2009292643B2 (en) * 2008-09-19 2016-02-18 Nektar Therapeutics Polymer conjugates of therapeutic peptides
EP2344200A2 (en) * 2008-09-19 2011-07-20 Nektar Therapeutics Modified therapeutics peptides, methods of their preparation and use
SI24318A (sl) 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji
RU2537033C1 (ru) * 2013-10-29 2014-12-27 Общество с ограниченной ответственностью "Полилаб" Способ применения растительного полисахарида в качестве радиопротектора и стимулятора колониеобразования стволовых клеток селезенки облученных животных
US10350293B2 (en) * 2016-08-23 2019-07-16 Pharmacotherapia d.o.o. Compositions and methods for treating symptoms associated with multiple sclerosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1279820A (en) * 1968-12-26 1972-06-28 Nissui Pharm Co Ltd Process for preparing mucoprotein and product obtained thereby

Also Published As

Publication number Publication date
EP0432400B1 (en) 1995-07-19
DE69021024T2 (de) 1996-01-11
US5288708A (en) 1994-02-22
ATE125266T1 (de) 1995-08-15
EP0432400A3 (en) 1991-07-03
EP0432400A2 (en) 1991-06-19
YU176089A (sh) 1992-09-07
GR3017787T3 (en) 1996-01-31
HU211038A9 (en) 1995-09-28
DE69021024D1 (de) 1995-08-24
DK0432400T3 (da) 1995-12-11

Similar Documents

Publication Publication Date Title
Dougherty Hematoporphyrin as a photosensitizer of tumors
SE9703191L (sv) Läkemedel för förbättring av muskelfunktionsdurationen eller behandling av muskelstörningar eller -sjukdom
BRPI0010612B8 (pt) vacinas
ES2076274T3 (es) Sustancia cpc farmacologicamente activa, proceso para su preparacion y su utilizacion en la terapia.
JPS5998015A (ja) 免疫賦活剤
DE69733089D1 (de) Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
EP1933945B1 (en) A pharmaceutical composition comprising mahanine useful for the treatment of prostate cancer
CA2252438A1 (en) Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
RU2443439C2 (ru) Способ лечения красного плоского лишая
AU731286B2 (en) Composition and method for treating herpes simplex
US7351554B2 (en) Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's
BR9915951A (pt) Processo para preparação de uma composição farmacêutica para uso como um medicamento antiarritmias com um bloqueio beta adrenérgico controlado, composição farmacêutica, preparação oral e parenteral para tratamento de doenças cardìacas em mamìferos, e, método de tratamento para as mesmas
TW201929874A (zh) 片仔癀及其製劑在治療帶狀皰疹中的用途
AR006202A1 (es) Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
CO4750645A1 (es) Metodo de preparacion de granulos que incorporan un medica- mento para uso farmaceutico
Panitch et al. Experimental herpes simplex encephalitis: Treatment with pyrimidine nucleosides
ES2052475T1 (es) Preparacion farmaceutica para el tratamiento de trastornos inmunoorganicos comprendiendo pp14 o anticuerpos pp14.
CN111939194A (zh) 一种治疗乳腺肿瘤、子宫肿瘤的中药配方及其制备方法
CN111358833A (zh) 夏枯草提取物及其在制备治疗甲状腺疾病药物中的应用
CN1074905A (zh) 吡咯基苯并二氮杂酮
EE9900346A (et) Viljatusevastane ja viljastumisvõimet tõstev ravim
RU94020307A (ru) Способ лечения синдрома паркинсонизма
CN1660349A (zh) 一种以裸花紫珠和血竭作为活性组合的药物组合物
RU1826911C (ru) Способ профилактики и лечени атеросклероза в эксперименте
JPS5821624A (ja) 慢性関節リウマチの治療剤

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 432400

Country of ref document: ES